Trials / Unknown
UnknownNCT05478109
A Clinical Trial of XZP-3287 for Material Balance
the Material Balance and Biotransformation Study of [14C] XZP-3287 in Healthy Chinese Male Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of \[14C\] XZP-3287
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]XZP-3287 | 360 mg suspension containing 50µCi of \[14C\] XZP-3287 |
Timeline
- Start date
- 2022-08-02
- Primary completion
- 2023-01-04
- Completion
- 2023-01-04
- First posted
- 2022-07-28
- Last updated
- 2022-07-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05478109. Inclusion in this directory is not an endorsement.